Safety, Tolerability, and Immunogenicity of CRV-101 in Healthy Adult Subjects

NCT03820414 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster
Varicella Zoster

Interventions

BIOLOGICAL: CRV 101
BIOLOGICAL: Placebo

Sponsor

Curevo Inc

Collaborators

[object Object]
[object Object]
[object Object]